Two of the country’s leading clinicians and researchers will join us to discuss the latest advances in preventing, diagnosis and treating cancer. We’ll discuss the latest finding about aspirin vs. breast cancer as well as the controversial findings that the PSA test may not be as good a predictor of prostate cancer as people had hoped. We will also find out about new drugs such as Gleevec, Iressa, Avastin and Velcade. Guests: Kim Lyerly,MD, Duke Comprehensive Cancer Center Sheldon Earp, MD, UNC Comprehensive Cancer Center